Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
Singh K, Hotchkiss K, Parney I, De Groot J, Sahebjam S, Sanai N, Platten M, Galanis E, Lim M, Wen P, Minniti G, Colman H, Cloughesy T, Mehta M, Geurts M, Arrillaga-Romany I, Desjardins A, Tanner K, Short S, Arons D, Duke E, Wick W, Bagley S, Ashley D, Kumthekar P, Verhaak R, Chalmers A, Patel A, Watts C, Fecci P, Batchelor T, Weller M, Vogelbaum M, Preusser M, Berger M, Khasraw M. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nature Medicine 2023, 29: 2402-2405. PMID: 37488293, DOI: 10.1038/s41591-023-02464-8.Peer-Reviewed Original ResearchConceptsCentral nervous systemOpportunity trialDrug development paradigmNervous systemTissue samplingGlioblastomaDrug discovery
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply